Acid-base chemistry of plasma: consolidation of the traditional and modern approaches from a mathematical and clinical perspective
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- acidobazická rovnováha MeSH
- algoritmy MeSH
- hydrogenuhličitany krev MeSH
- ionty MeSH
- krevní plazma chemie MeSH
- lidé MeSH
- monitorování fyziologických funkcí metody trendy MeSH
- poruchy acidobazické rovnováhy * MeSH
- pufry MeSH
- software MeSH
- teoretické modely MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- hydrogenuhličitany MeSH
- ionty MeSH
- pufry MeSH
OBJECTIVE: Debate still exists as to whether the Stewart (modern) or traditional model of acid-base chemistry is best in assessing the acid-base status of critically ill patients. Recent studies have compared various parameters from the modern and traditional approaches, assessing the clinical usefulness of parameters such as base excess, anion gap, corrected anion gap, strong ion difference and strong ion gap. To compare the clinical usefulness of these parameters, and hence the different approaches, requires a clear understanding of their meaning; a task only possible through understanding the mathematical basis of the approaches. The objective of this paper is to provide this understanding, limiting the mathematics to a necessary minimum. METHOD: The first part of this paper compares the mathematics of these approaches, with the second part illustrating the clinical usefulness of the approaches using a patient example. RESULTS: This analysis illustrates the almost interchangeable nature of the equations and that the same clinical conclusions can be drawn regardless of the approach adopted. CONCLUSIONS: Although different in their concepts, the traditional and modern approaches based on mathematical models can be seen as complementary giving, in principle, the same information about the acid-base status of plasma.
Zobrazit více v PubMed
Crit Care Resusc. 2004 Dec;6(4):285-94 PubMed
Scand J Clin Lab Invest. 1960;12:177-86 PubMed
Anesth Analg. 2003 Apr;96(4):919-922 PubMed
J Appl Physiol (1985). 1997 Jul;83(1):297-311 PubMed
Crit Care Med. 1999 Aug;27(8):1577-81 PubMed
Can J Physiol Pharmacol. 1983 Dec;61(12):1444-61 PubMed
Scand J Clin Lab Invest Suppl. 1977;146:15-20 PubMed
Shock. 2008 Jun;29(6):662-6 PubMed
Pharmacotherapy. 2008 Aug;28(8):984-91 PubMed
Intensive Care Med. 2009 Feb;35(2):189-91 PubMed
Medicine (Baltimore). 1977 Jan;56(1):38-54 PubMed
Scand J Clin Lab Invest. 1971 May;27(3):239-45 PubMed
Intensive Care Med. 2009 Feb;35(2):232-9 PubMed
Medicine (Baltimore). 1948 May;27(2):223-242 PubMed
Eur J Appl Physiol. 2010 Feb;108(3):483-94 PubMed
Crit Rev Biomed Eng. 2005;33(3):209-64 PubMed
J Appl Physiol (1985). 2003 Dec;95(6):2333-44 PubMed
Arch Intern Med. 1990 Feb;150(2):311-3 PubMed
N Engl J Med. 1963 Jun 20;268:1382-8 PubMed
Acta Med Scand. 1964;176:SUPPL 422: 1+ PubMed
Am J Respir Crit Care Med. 2000 Dec;162(6):2246-51 PubMed
J Appl Physiol (1985). 2003 Aug;95(2):620-30 PubMed
Crit Care Med. 2008 Mar;36(3):752-8 PubMed
J Appl Physiol (1985). 1999 Apr;86(4):1421-7 PubMed
Scand J Clin Lab Invest. 1962;14:598-604 PubMed
Crit Care Med. 1998 Nov;26(11):1807-10 PubMed
J Appl Physiol (1985). 2001 Sep;91(3):1364-71 PubMed
J Appl Physiol (1985). 1999 Jan;86(1):326-34 PubMed
Crit Care. 2005 Oct 5;9(5):500-7 PubMed
J Lab Clin Med. 1992 Nov;120(5):713-9 PubMed
Acta Anaesthesiol Scand Suppl. 1995;107:123-8 PubMed
J Lab Clin Med. 1991 Jun;117(6):453-67 PubMed